Stock Track | GeneDx Holdings Soars on Strong Q3 Results and Bright Outlook

Stock Track10-31

Shares of GeneDx Holdings (NASDAQ:WGS) surged 5.62% on October 30, 2024, following the company's impressive third-quarter 2024 results and raised full-year guidance. The genetic testing firm reported significant revenue growth, margin expansion, and achieved profitability for the first time since its inception.

GeneDx Holdings' revenue from continuing operations reached $76.6 million in the third quarter, a remarkable 52% increase year-over-year. This growth was primarily driven by strong demand for the company's exome and genome testing services, which contributed $60 million in revenue, up 77% from the prior year. Exome and genome test volumes also grew substantially, rising 46% year-over-year to over 19,000 tests.

The company's adjusted gross profit soared 103% year-over-year to $49.3 million, resulting in an impressive gross margin of 64%, up from 48% a year ago. This margin expansion was attributed to better average reimbursement rates, lower costs per test, and a favorable shift in product mix towards higher-margin exome and genome testing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1199137654?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-31 01:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199137654","market":"hk","top_or_hot":-1,"title":"Stock Track | GeneDx Holdings Soars on Strong Q3 Results and Bright Outlook","media":"Stock Track","content":"<p>Shares of GeneDx Holdings (NASDAQ:WGS) surged 5.62% on October 30, 2024, following the company's impressive third-quarter 2024 results and raised full-year guidance. The genetic testing firm reported significant revenue growth, margin expansion, and achieved profitability for the first time since its inception.</p>\n\n<p>GeneDx Holdings' revenue from continuing operations reached $76.6 million in the third quarter, a remarkable 52% increase year-over-year. This growth was primarily driven by strong demand for the company's exome and genome testing services, which contributed $60 million in revenue, up 77% from the prior year. Exome and genome test volumes also grew substantially, rising 46% year-over-year to over 19,000 tests.</p>\n\n<p>The company's adjusted gross profit soared 103% year-over-year to $49.3 million, resulting in an impressive gross margin of 64%, up from 48% a year ago. This margin expansion was attributed to better average reimbursement rates, lower costs per test, and a favorable shift in product mix towards higher-margin exome and genome testing.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | GeneDx Holdings Soars on Strong Q3 Results and Bright Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | GeneDx Holdings Soars on Strong Q3 Results and Bright Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n2024-10-31 01:14 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of GeneDx Holdings (NASDAQ:WGS) surged 5.62% on October 30, 2024, following the company's impressive third-quarter 2024 results and raised full-year guidance. The genetic testing firm reported ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WGS","symbol_name":"GeneDx Holdings","start_time":0,"source_url":"","article_id":"1199137654","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199137654","pubTimestamp":1730308469,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of GeneDx Holdings  surged 5.62% on October 30, 2024, following the company's impressive third-quarter 2024 results and raised full-year guidance. The genetic testing firm reported significant revenue growth, margin expansion, and achieved profitability for the first time since its inception.GeneDx Holdings' revenue from continuing operations reached $76.6 million in the third quarter, a remarkable 52% increase year-over-year. This growth was primarily driven by strong demand for the comp","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"WGS":"GeneDx Holdings"},"translate_title":"股票赛道GeneDx Holdings因强劲的第三季度业绩和光明的前景而飙升","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WGS":1},"content_text":"Shares of GeneDx Holdings (NASDAQ:WGS) surged 5.62% on October 30, 2024, following the company's impressive third-quarter 2024 results and raised full-year guidance. The genetic testing firm reported significant revenue growth, margin expansion, and achieved profitability for the first time since its inception.\nGeneDx Holdings' revenue from continuing operations reached $76.6 million in the third quarter, a remarkable 52% increase year-over-year. This growth was primarily driven by strong demand for the company's exome and genome testing services, which contributed $60 million in revenue, up 77% from the prior year. Exome and genome test volumes also grew substantially, rising 46% year-over-year to over 19,000 tests.\nThe company's adjusted gross profit soared 103% year-over-year to $49.3 million, resulting in an impressive gross margin of 64%, up from 48% a year ago. This margin expansion was attributed to better average reimbursement rates, lower costs per test, and a favorable shift in product mix towards higher-margin exome and genome testing.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1199137654"}